147 related articles for article (PubMed ID: 35435050)
1. ERG Expression is Helpful in Differentiating T-Lymphoblastic Lymphoma from Thymoma.
Huang W; Zhang W; Zeng L; Liao S; Liu F; Li L
Int J Surg Pathol; 2023 Apr; 31(2):137-141. PubMed ID: 35435050
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of LMO2 immunohistochemistry in distinguishing T-lymphoblastic leukemia/lymphoma from thymoma.
Bansal D; Pasricha S; Gupta G; Sharma A; Durga G; Kamboj M; Mehta A
Indian J Pathol Microbiol; 2024; 67(1):141-144. PubMed ID: 38358204
[TBL] [Abstract][Full Text] [Related]
3. Concurrent thymoma, thymic carcinoma, and T lymphoblastic leukemia/lymphoma in an anterior mediastinal mass.
Ito J; Yoshida A; Maeshima AM; Nakagawa K; Watanabe S; Kobayashi Y; Fukuhara S; Tsuta K
Pathol Res Pract; 2015 Sep; 211(9):693-6. PubMed ID: 26150396
[TBL] [Abstract][Full Text] [Related]
4. T-Lymphoblastic Leukemia/Lymphoma and Thymoma: A Case Report and Review of the Literature of a Rare Association.
Mizrahi N; Kugler E; Hayman L; Yeshurun M; Grossman A; Raanani P; Wolach O
Acta Haematol; 2022; 145(1):106-111. PubMed ID: 34537764
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing thymoma from T-lymphoblastic leukaemia/lymphoma: a case-based evaluation.
Boddu P; Thakral B; Alhuraiji A; Pemmaraju N; Kadia T; Ohanian M; Ravandi F; Jabbour E; Wierda W; Khoury JD; Jain N
J Clin Pathol; 2019 Mar; 72(3):251-257. PubMed ID: 30467242
[TBL] [Abstract][Full Text] [Related]
6. LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma.
Jevremovic D; Roden AC; Ketterling RP; Kurtin PJ; McPhail ED
Am J Clin Pathol; 2016 Feb; 145(2):180-90. PubMed ID: 26796495
[TBL] [Abstract][Full Text] [Related]
7. NOTCH1 intracellular domain immunohistochemistry as a diagnostic tool to distinguish T-lymphoblastic lymphoma from thymoma.
Jegalian AG; Bodo J; Hsi ED
Am J Surg Pathol; 2015 Apr; 39(4):565-72. PubMed ID: 25517959
[TBL] [Abstract][Full Text] [Related]
8. T-cell lymphoblastic leukemia/lymphoma presenting in a recurrent thymoma.
Macon WR; Rynalski TH; Swerdlow SH; Cousar JB
Mod Pathol; 1991 Jul; 4(4):524-8. PubMed ID: 1924284
[TBL] [Abstract][Full Text] [Related]
9. Ectopic cervical thymoma: a mimic of T-lymphoblastic lymphoma.
Chang ST; Chuang SS
Pathol Res Pract; 2003; 199(9):633-5. PubMed ID: 14621201
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
Li S; Juco J; Mann KP; Holden JT
Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
[TBL] [Abstract][Full Text] [Related]
11. ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer.
Thoms JA; Birger Y; Foster S; Knezevic K; Kirschenbaum Y; Chandrakanthan V; Jonquieres G; Spensberger D; Wong JW; Oram SH; Kinston SJ; Groner Y; Lock R; MacKenzie KL; Göttgens B; Izraeli S; Pimanda JE
Blood; 2011 Jun; 117(26):7079-89. PubMed ID: 21536859
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2 maturation pattern in T-cells distinguishes thymic neoplasm/hyperplasia, T-lymphoblastic lymphoma, and reactive lymph nodes.
Ward N; Baqai J; Zehnpfennig A; Fine N; Huang J; Smith MD
Cytometry B Clin Cytom; 2018 May; 94(3):444-450. PubMed ID: 28718205
[TBL] [Abstract][Full Text] [Related]
13. Thymoma mimicking lymphoblastic lymphoma: a pitfall in fine-needle aspiration biopsy interpretation.
Friedman HD; Hutchison RE; Kohman LJ; Powers CN
Diagn Cytopathol; 1996 Mar; 14(2):165-9; discussion 169-71. PubMed ID: 8964175
[TBL] [Abstract][Full Text] [Related]
14. Metastatic thymoma: a case report and immunohistological analysis.
Salter DM; Krajewski AS
J Clin Pathol; 1986 Mar; 39(3):275-8. PubMed ID: 3485661
[TBL] [Abstract][Full Text] [Related]
15. The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia.
Coskun E; von der Heide EK; Schlee C; Kühnl A; Gökbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Leuk Res; 2011 Feb; 35(2):208-13. PubMed ID: 20570349
[TBL] [Abstract][Full Text] [Related]
16. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
Brar N; Butzmann A; Kumar J; Peerani R; Morgan EA; Grigoriadis G; Kumar B; Tatarczuch RM; Warnke RA; Ohgami RS
Histopathology; 2020 Dec; 77(6):984-988. PubMed ID: 32526041
[TBL] [Abstract][Full Text] [Related]
17. T-cell acute lymphoblastic leukemia with transient pure red cell aplasia associated with myasthenia gravis and invasive thymoma.
Nishioka R; Nakajima S; Morimoto Y; Suzuki H; Nakamura H; Suzuki M
Intern Med; 1995 Feb; 34(2):127-30. PubMed ID: 7727878
[TBL] [Abstract][Full Text] [Related]
18. Tumours of the thymus and their nomenclature.
Otto HF
Virchows Arch A Pathol Anat Histopathol; 1991; 419(4):257-60. PubMed ID: 1949607
[No Abstract] [Full Text] [Related]
19. ERG induces a mesenchymal-like state associated with chemoresistance in leukemia cells.
Mochmann LH; Neumann M; von der Heide EK; Nowak V; Kühl AA; Ortiz-Tanchez J; Bock J; Hofmann WK; Baldus CD
Oncotarget; 2014 Jan; 5(2):351-62. PubMed ID: 24504051
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic control of differential expression of specific ERG isoforms in acute T-lymphoblastic leukemia.
Bohne A; Schlee C; Mossner M; Thibaut J; Heesch S; Thiel E; Hofmann WK; Baldus CD
Leuk Res; 2009 Jun; 33(6):817-22. PubMed ID: 19108891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
